Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A14396 | 29428103 | Hepatobiliary Pancreat Dis Int | Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population. | 2018 | Details |
| A14397 | 29427497 | Liver Int | Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why liver biopsy is essential. | 2018 | Details |
| A14398 | 29427496 | Liver Int | Liver diseases: A major, neglected global public health problem requiring urgent actions and large-scale screening. | 2018 | Details |
| A14399 | 29427494 | Liver Int | Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Non-invasive tests are enough. | 2018 | Details |
| A14400 | 29427492 | Liver Int | Future therapy for non-alcoholic fatty liver disease. | 2018 | Details |
| A14401 | 29427488 | Liver Int | Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future. | 2018 | Details |
| A14402 | 29427486 | Liver Int | Management of patients with non-alcoholic steatohepatitis (NASH) in real life. | 2018 | Details |
| A14403 | 29427339 | Cancer Sci | Stearate-to-palmitate ratio modulates endoplasmic reticulum stress and cell apoptosis in non-B non-C hepatoma cells. | 2018 | Details |
| A14404 | 29426937 | Nat Commun | Ultraconserved element uc.372 drives hepatic lipid accumulation by suppressing miR-195/miR4668 maturation. | 2018 | Details |
| A14405 | 29425901 | Clin Imaging | Multicenter, multivendor phantom study to validate proton density fat fraction and T2* values calculated using vendor-provided 6-point DIXON methods. | 2018 | Details |
| A14406 | 29425759 | Exp Mol Pathol | Expression of proteins upregulated in hepatocellular carcinoma in patients with alcoholic hepatitis (AH) compared to non-alcoholic steatohepatitis (NASH): An immunohistochemical analysis of candidate proteins. | 2018 | Details |
| A14407 | 29425212 | PLoS One | Insulin resistance in lean and overweight non-diabetic Caucasian adults: Study of its relationship with liver triglyceride content, waist circumference and BMI. | 2018 | Details |
| A14408 | 29424123 | J Gastroenterol Hepatol | Mouse models of non-alcoholic steatohepatitis: A reflection on recent literature. | 2018 | Details |
| A14409 | 29421523 | Transl Res | Maraviroc improves hepatic triglyceride content but not inflammation in a murine nonalcoholic fatty liver disease model induced by a chronic exposure to high-fat diet. | 2018 | Details |
| A14410 | 29420067 | Am J Physiol Gastrointest Liver Physiol | Organic solute transporter OSTα/β is overexpressed in nonalcoholic steatohepatitis and modulated by drugs associated with liver injury. | 2018 | Details |
| A14411 | 29420066 | Am J Physiol Gastrointest Liver Physiol | CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease. | 2018 | Details |
| A14412 | 29419789 | Nutrients | Aged Oolong Tea Reduces High-Fat Diet-Induced Fat Accumulation and Dyslipidemia by Regulating the AMPK/ACC Signaling Pathway. | 2018 | Details |
| A14413 | 29419350 | Ultrastruct Pathol | Swim exercise training ameliorates hepatocyte ultrastructural alterations in rats fed on a high fat and sugar diet. | 2018 | Details |
| A14415 | 29417009 | J Family Med Prim Care | Hepatobiliary dysfunction in Type-2 diabetes mellitus. | 2022 | Details |
| A14416 | 29416808 | Oncotarget | Increased risk of cerebrovascular accident related to non-alcoholic fatty liver disease: a meta-analysis. | 2017 | Details |
| A14417 | 29416063 | Nat Commun | AhR and SHP regulate phosphatidylcholine and S-adenosylmethionine levels in the one-carbon cycle. | 2018 | Details |
| A14418 | 29415050 | PLoS One | Associations of hyperuricemia and obesity with remission of nonalcoholic fatty liver disease among Chinese men: A retrospective cohort study. | 2018 | Details |
| A14419 | 29414910 | Molecules | Hepatoprotective Effects of a Functional Formula of Three Chinese Medicinal Herbs: Experimental Evidence and Network Pharmacology-Based Identification of Mechanism of Action and Potential Bioactive Components. | 2018 | Details |
| A14420 | 29414781 | J Biol Chem | Maresin 1 attenuates NAFLD by suppression of endoplasmic reticulum stress via AMPK-SERCA2b pathway. | 2018 | Details |
| A14421 | 29414684 | Cell Metab | Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis. | 2018 | Details |
| A14422 | 29414249 | Annu Rev Pathol | Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14423 | 29413998 | Curr Opin Pharmacol | Lipid-lowering treatment in peripheral artery disease. | 2018 | Details |
| A14424 | 29413959 | Redox Biol | Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches. | 2018 | Details |
| A14425 | 29412830 | Peptides | Glucagon receptor signaling in metabolic diseases. | 2018 | Details |
| A14426 | 29411334 | J Cell Commun Signal | Regulation and bioactivity of the CCN family of genes and proteins in obesity and diabetes. | 2018 | Details |
| A14427 | 29411270 | Adv Ther | Haptoglobin Genotype and Vitamin E Versus Placebo for the Treatment of Nondiabetic Patients with Nonalcoholic Steatohepatitis in China: A Multicenter, Randomized, Placebo-Controlled Trial Design. | 2018 | Details |
| A14428 | 29411128 | Eur J Appl Physiol | Effects of sprint interval training on ectopic lipids and tissue-specific insulin sensitivity in men with non-alcoholic fatty liver disease. | 2018 | Details |
| A14429 | 29410708 | Diabetol Metab Syndr | Dietary fat stimulates development of NAFLD more potently than dietary fructose in Sprague-Dawley rats. | 2018 | Details |
| A14431 | 29409822 | Metabolism | Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults. | 2018 | Details |
| A14432 | 29409538 | BMC Res Notes | Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis. | 2018 | Details |
| A14433 | 31294396 | J Can Assoc Gastroenterol | 2017 Canadian Association of Gastroenterology Educational Needs Assessment Report. | 2018 | Details |
| A14434 | 29408750 | Eur J Obstet Gynecol Reprod Biol | Diurnal rhythm of follicle-stimulating hormone is associated with nonalcoholic fatty liver disease in a Chinese elderly population. | 2018 | Details |
| A14435 | 29408694 | J Hepatol | Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. | 2018 | Details |
| A14436 | 29408602 | Mol Cell Endocrinol | Hepatic NAD+ levels and NAMPT abundance are unaffected during prolonged high-fat diet consumption in C57BL/6JBomTac mice. | 2018 | Details |
| A14438 | 29406832 | Can J Physiol Pharmacol | Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates nonalcoholic fatty liver disease. | 2018 | Details |
| A14439 | 29406564 | J Viral Hepat | Current but not past hepatitis B virus infection is associated with a decreased risk of nonalcoholic fatty liver disease in the Chinese population: A case-control study with propensity score analysis. | 2018 | Details |
| A14440 | 29406435 | Eur J Gastroenterol Hepatol | Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological reference. | 2018 | Details |
| A14441 | 29405466 | J Gastroenterol Hepatol | Prediction of carotid intima-media thickness in obese patients with low prevalence of comorbidities by serum copper bioavailability. | 2018 | Details |
| A14442 | 29404772 | Eur Radiol | Imaging prediction of nonalcoholic steatohepatitis using computed tomography texture analysis. | 2018 | Details |
| A14443 | 29404527 | Hepatol Commun | Natural history of nonalcoholic fatty liver disease: A prospective follow-up study with serial biopsies. | 2017 | Details |
| A14444 | 29404514 | Hepatol Commun | Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice. | 2017 | Details |
| A14445 | 29404513 | Hepatol Commun | Quantitative assessment of liver fibrosis reveals a nonlinear association with fibrosis stage in nonalcoholic fatty liver disease. | 2017 | Details |
| A14446 | 29404512 | Hepatol Commun | Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long-term follow-up study. | 2017 | Details |
| A14448 | 29404500 | Hepatol Commun | Progression of liver fibrosis is associated with non-liver-related mortality in patients with nonalcoholic fatty liver disease. | 2017 | Details |
| A14449 | 29404494 | Hepatol Commun | Use of Mac-2 binding protein as a biomarker for nonalcoholic fatty liver disease diagnosis. | 2017 | Details |
| A14450 | 29404483 | Hepatol Commun | Characteristics of hepatic insulin-sensitive nonalcoholic fatty liver disease. | 2017 | Details |
| A14451 | 29404470 | Hepatol Commun | Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease. | 2017 | Details |
| A14452 | 29404465 | Hepatol Commun | Nonalcoholic fatty liver disease and the ongoing role of liver biopsy evaluation. | 2017 | Details |
| A14453 | 29404440 | Hepatol Commun | Engineered FGF19 eliminates bile acid toxicity and lipotoxicity leading to resolution of steatohepatitis and fibrosis in mice. | 2017 | Details |
| A14454 | 29404433 | Hepatol Commun | Nonalcoholic fatty liver disease-related cirrhosis is commonly unrecognized and associated with hepatocellular carcinoma. | 2017 | Details |
| A14455 | 29402900 | Sci Rep | Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH. | 2018 | Details |
| A14456 | 29402822 | Med Princ Pract | Metabolic Syndrome Is Associated with Health-Related Quality of Life in Suspected Patients with Nonalcoholic Steatohepatitis. | 2018 | Details |
| A14457 | 29402657 | Diabetes Metab Syndr | Nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and its association with cardiovascular disease. | 2018 | Details |
| A14458 | 29401710 | Nutrients | Dietary Iron Supplementation Alters Hepatic Inflammation in a Rat Model of Nonalcoholic Steatohepatitis. | 2018 | Details |
| A14459 | 29401451 | Cell Syst | Broad Views of Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A14460 | 29400692 | J Clin Invest | Hippo-mediated suppression of IRS2/AKT signaling prevents hepatic steatosis and liver cancer. | 2018 | Details |
| A14461 | 29400110 | Free Radic Res | Scutellarin ameliorates nonalcoholic fatty liver disease through the PPARγ/PGC-1α-Nrf2 pathway. | 2018 | Details |
| A14462 | 29399555 | Adv Pharm Bull | Effect of Daily Caper Fruit Pickle Consumption on Disease Regression in Patients with Non-Alcoholic Fatty Liver Disease: a Double-Blinded Randomized Clinical Trial. | 2017 | Details |
| A14463 | 29399359 | SAGE Open Med | Association between smoking and non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2018 | Details |
| A14464 | 29399288 | World J Hepatol | Vitamin D levels do not predict the stage of hepatic fibrosis in patients with non-alcoholic fatty liver disease: A PRISMA compliant systematic review and meta-analysis of pooled data. | 2018 | Details |
| A14465 | 29399277 | World J Hepatol | Fatty liver disease, an emerging etiology of hepatocellular carcinoma in Argentina. | 2018 | Details |
| A14466 | 29399276 | World J Hepatol | Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease. | 2018 | Details |
| A14467 | 29399273 | World J Hepatol | Role of inflammatory response in liver diseases: Therapeutic strategies. | 2018 | Details |
| A14468 | 29399077 | Exp Ther Med | Relationship between intestinal flora and inflammatory factors in patients with nonalcoholic steatohepatitis. | 2017 | Details |
| A14469 | 29398867 | World J Gastroenterol | Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice. | 2018 | Details |
| A14470 | 29398749 | Iran J Med Sci | Regression of Nonalcoholic Fatty Liver Disease with Zinc and Selenium Co-supplementation after Disease Progression in Rats. | 2018 | Details |
| A14471 | 29398414 | Dig Liver Dis | Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects. | 2017 | Details |
| A14472 | 29398327 | J Diabetes Complications | Differing clinical phenotype for higher alanine-aminotransferase (ALT) compared with high-risk NAFLD fibrosis score in type 2 diabetes mellitus. | 2017 | Details |
| A14473 | 29397594 | Zhonghua Nei Ke Za Zhi | [Efficacy of probiotics on the treatment of non-alcoholic fatty liver disease]. | 2018 | Details |
| A14474 | 29396908 | Mol Nutr Food Res | Mice Fed a High-Cholesterol Diet Supplemented with Quercetin-3-Glucoside Show Attenuated Hyperlipidemia and Hyperinsulinemia Associated with Differential Regulation of PCSK9 and LDLR in their Liver and Pancreas. | 2018 | Details |
| A14475 | 29396131 | Dig Liver Dis | Donor PNPLA3 rs738409 genotype is a risk factor for graft steatosis. A post-transplant biopsy-based study. | 2018 | Details |
| A14476 | 29395967 | Growth Horm IGF Res | Factors correlated with serum insulin-like growth factor-I levels in health check-up subjects. | 2018 | Details |
| A14477 | 29393027 | Ugeskr Laeger | [Controlled attenuation parameter is a novel technique in screening for non-alcoholic fatty liver disease]. | 2018 | Details |
| A14478 | 29391755 | World J Gastroenterol | circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling. | 2018 | Details |
| A14479 | 29391513 | Sci Rep | A Systematic Machine Learning Based Approach for the Diagnosis of Non-Alcoholic Fatty Liver Disease Risk and Progression. | 2018 | Details |
| A14480 | 29391432 | Sci Rep | Systems Analysis of the Liver Transcriptome in Adult Male Zebrafish Exposed to the Plasticizer (2-Ethylhexyl) Phthalate (DEHP). | 2018 | Details |
| A14481 | 29391222 | Adv Drug Deliv Rev | MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis. | 2018 | Details |
| A14482 | 29391015 | Environ Health | Bisphenol a increases risk for presumed non-alcoholic fatty liver disease in Hispanic adolescents in NHANES 2003-2010. | 2018 | Details |
| A14483 | 29390925 | Crit Rev Clin Lab Sci | Diagnostic criteria and contributors to Gilbert's syndrome. | 2018 | Details |
| A14484 | 29390103 | Nephrol Dial Transplant | Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease. | 2019 | Details |
| A14485 | 29389988 | PLoS One | Implication of trans-11,trans-13 conjugated linoleic acid in the development of hepatic steatosis. | 2018 | Details |
| A14486 | 29387723 | Biomed Res Int | The Common Mechanisms of Sarcopenia and NAFLD. | 2017 | Details |
| A14487 | 29386434 | Yakugaku Zasshi | [From a Ph.D. Thesis: Understanding the Past, Predicting the Future]. | 2018 | Details |
| A14488 | 29386216 | BMJ Case Rep | High-dose steroids as a therapeutic option in the management of spur cell haemolytic anaemia. | 2018 | Details |
| A14489 | 29386155 | Pak J Pharm Sci | Therapeutic effect of alkaloids and glycosides of colocynth seeds on liver injury, associated with metabolic syndrome in wistar rats, subject to nutritional stress. | 2018 | Details |
| A14490 | 29385682 | Nutrients | Serum Antioxidant Associations with Metabolic Characteristics in Metabolically Healthy and Unhealthy Adolescents with Severe Obesity: An Observational Study. | 2018 | Details |
| A14491 | 29385134 | PLoS One | Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers. | 2018 | Details |
| A14492 | 29385034 | Nutrients | Liver Fat Scores Moderately Reflect Interventional Changes in Liver Fat Content by a Low-Fat Diet but Not by a Low-Carb Diet. | 2018 | Details |
| A14493 | 29384795 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease: biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina. | 2018 | Details |
| A14494 | 29382663 | Diabetes | Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis. | 2018 | Details |
| A14495 | 29381809 | Hepatology | Tumor Progression Locus 2 in Hepatocytes Potentiates Both Liver and Systemic Metabolic Disorders in Mice. | 2018 | Details |
| A14496 | 29381754 | PLoS One | Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection. | 2018 | Details |
| A14497 | 29381226 | J Gastroenterol Hepatol | Risk for the development of non-alcoholic fatty liver disease: A prospective study. | 2018 | Details |
| A14498 | 29380318 | Methods Mol Biol | Assessment of Fatty Liver in Models of Disease Programming. | 2018 | Details |
| A14499 | 29380062 | J Gastroenterol | The profiling of plasma free amino acids and the relationship between serum albumin and plasma-branched chain amino acids in chronic liver disease: a single-center retrospective study. | 2018 | Details |